The Society for Immunotherapy of Cancer (SITC) is pleased to offer the second FREE webinar in the SITC-NCI Computational Immuno-oncology live webinar series, "Guidelines and Best Practices on Designing Clinical Trials with Exploratory Surrogate Endpoints and CDX: Computational Science in Immuno-oncology".
Webinar Description: Exploratory surrogate endpoints and companion diagnostics (CDX) are transforming clinical trial design in immuno-oncology, crucial for advancing personalized medicine. By incorporating these innovative approaches, researchers can gain early insights into treatment efficacy, enhancing the likelihood of successful drug approval. Join us to explore how these guidelines and best practices can shape the future of clinical trials and drive progress in immunotherapy.
Key leaders in the field who are experts in their respective fields will provide an overview of the current state of the science and address questions about its future.
- Academic Faculty: Janice M. Mehnert, MD – NYU Langone Health
- Industry Speaker: Rui Sammi Tang, PhD, MBA – Astellas Pharma US, Inc.
- Moderator: Julie Rytlewski, PhD – Bristol Myers Squibb
An interactive Q&A session will follow the topic overview, providing participants with the opportunity to ask in-depth questions of the faculty